HBIO icon

Harvard Bioscience
HBIO

Overview Fund Activity

74 hedge funds and large institutions have $87.4M invested in Harvard Bioscience in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
74
Holders Change
-3
Holders Change %
-3.9%
% of All Funds
2.14%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
6
Increased
28
Reduced
19
Closed
9
Calls
$19K
Puts
$20K
Net Calls
-$1K
Net Calls Change
+$8K

Top Buyers

1
FLAM
1
First Light Asset Management
Minnesota
$4.56M
2
PM
2
Penbrook Management
New York
$5.26M
3
JAM
3
Jupiter Asset Management
United Kingdom
$1.79M
4
KAM
4
Knightsbridge Asset Management
California
$1.25M
5
BIT
5
BlackRock Institutional Trust
California
$8.25M

Top Sellers

1
Fuller & Thaler Asset Management
1
Fuller & Thaler Asset Management
California
$0
2
FCAM
2
F&C Asset Management
United Kingdom
$3.98M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
CSM
4
Central Square Management
Illinois
$455K
5
Morgan Stanley
5
Morgan Stanley
New York
$814K
Name Holding Trade Value Shares
Change 		Shares
Change %
VKH
76
Virtu KCG Holdings
New York
– -$104K -22,129 Closed
Group One Trading
77
Group One Trading
Illinois
– -$100K -21,212 Closed
TDC
78
Thompson Davis & Co
Virginia
– -$87K -18,500 Closed
AIC
79
Atlantic Investment Company
Georgia
– -$62K -13,240 Closed
Millennium Management
80
Millennium Management
New York
– -$61K -12,935 Closed
CL
81
CSS LLC
Illinois
– -$50K -10,600 Closed
TRCT
82
Tower Research Capital (TRC)
New York
– -$4K -821 Closed
1 2 3
4